Global Molecular Diagnostics Market-Focus on Infectious Diseases

The latest trending report Global Molecular Diagnostics Market-Focus on Infectious Diseases (HPV/Chlamydia/Gonorrhea) & Genetic Testing (HLA) - Industry Outlook 2022 offered by DecisionDatabases.com in an informative study covering the market with detailed analysis. The report will assist reader with better understanding and decision making.

Browse the complete report and table of contents @

http://www.decisiondatabases.com/ip/11914-molecular-diagnostics-industry-market-report

Molecular diagnostics is used for detecting patient’s susceptibility to a disease by tests for   detecting and characterizing pathogenic mutations in DNA and RNA samples. It is the most dynamic segment of the global in vitro diagnostics market, given the advantages of precise genetic information over traditional tests. Molecular diagnostics in healthcare has been disseminating around the world at a robust growth rate due its unique ability to unlock molecular information of patients. The market has burgeoned in span of 25 years

In terms of market structure, molecular diagnostics industry is classified into three broad categories - clinical infectious disease, genomics and blood donor screening. The clinical infectious disease segment has two sub-segments: virology and bacteriology tests. The genomics segment is further sub-divided into genetic diseases and disorders, cancer testing, HLA testing, and pharmacogenetic testing. Infectious diseases are the largest segment of molecular diagnostics market.

Growth of the industry is fuelled by prevalence of reproductive infectious diseases such as Chlamydia and Gonorrhea, surge in various types of oncology diagnostics, ageing population and government’s mandate on regular screening of HPV and CT/NG. However, complex regulatory framework and lack of clarity on reimbursement are the major factors restraining the growth of the molecular diagnostics market.  Key trends prevailing in the industry includes rise in number of strategic industry alliances and use of Next Generation Sequencing (NGS) in clinical molecular diagnostics.

Major industry players operating in the market include Roche Holding AG, Novartis AG, Hologic Inc, Abbott Diagnostics, Becton Dickinson and Qiagen NV, among others. Roche Holdings, Novartis AG, Hologic Inc and Qiagen NV are profiled herein based on attributes such as business overview, product segments, financial and business strategies.

Free Download sample pages of Molecular Diagnostics Industry @
http://www.decisiondatabases.com/contact/download-sample-11923

1. Executive Summary

2. Research Methodology

3. Introduction

4. Molecular Diagnostic Market

5. Global Molecualr Diagnostics Market Segmentation

6. Global Molecular Diagnostics Market Dynamics

7. Competitive Landscape

8. Company Profiles

….

Purchase the complete Molecular Diagnostics Research Report @
http://www.decisiondatabases.com/contact/buy-now-11923

About-Us:

DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.

Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.

For more details:

DecisionDatabases.com

E Mail:  sales@decisiondatabases.com

Phone: +91 99 28 237112

Web: www.decisiondatabases.com/